Identification of potential Indonesian marine invertebrate bioactive compounds as TMPRSS2 and SARS-CoV-2 Omicron spike protein inhibitors through computational screening
Authors:
Open Access
- 16 May 2023
- journal article
- research article
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 16 (9) , 104984
Abstract
The coronavirus pandemic led to the announcement of a worldwide health emergency. The SARS-CoV-2 Omicron variant, which swiftly spread worldwide, has fueled existing challenges. Appropriate medication is necessary to avoid severe SARS-CoV-2 disease. The human TMPRSS2 and SARS-CoV-2 Omicron spike protein, which are required for viral entry into the host phase, were identified as the target proteins through computational screening. Structure-based virtual screening; molecular docking; absorption, distribution, metabolism, excretion, and toxicity (ADMET) analysis; and molecular dynamics simulation were the methods applied for TMPRSS2 and spike protein inhibitors. Bioactive marine invertebrates from Indonesia were employed as test ligands. Camostat and nafamostat (co-crystal) were utilized as reference ligands against TMPRSS2, whereas mefloquine was used as a reference ligand against spike protein. Following a molecular docking and dynamics simulation, we found that acanthomanzamine C has remarkable effectiveness against TMPRSS2 and spike protein. Compared to camostat (-8.25 kcal/mol), nafamostat (-6.52 kcal/mol), and mefloquine (-6.34 kcal/mol), acanthomanzamine C binds to TMPRSS2 and spike protein with binding energies of −9.75 kcal/mol and −9.19 kcal/mol, respectively. Furthermore, slight variances in the MD simulation demonstrated consistent binding to TMPRSS2 and spike protein after the initial 50 ns. These results are highly valuable in the search for a treatment for SARS-CoV-2 infection.Keywords
This publication has 35 references indexed in Scilit:
- Tackling SARS-CoV-2: Proposed Targets and Repurposed DrugsFuture Medicinal Chemistry, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion AssayAntimicrobial Agents and Chemotherapy, 2016
- Protease inhibitors targeting coronavirus and filovirus entryAntiviral Research, 2015
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus InfectionAntimicrobial Agents and Chemotherapy, 2014
- Implementation of the Hungarian Algorithm to Account for Ligand Symmetry and Similarity in Structure-Based DesignJournal of Chemical Information and Modeling, 2014
- Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral researchAntiviral Research, 2013
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Mollamides B and C, Cyclic Hexapeptides from the Indonesian Tunicate Didemnum molleJournal of Natural Products, 2008
- Modeling of loops in protein structuresProtein Science, 2000